Table 3.
Summary of 28-day lorcaserin treatment on clinical chemistry and major organ weights
Clinical chemistry |
Percent organ weights |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
ALB | GLOB | AST | ALT | ALP | TBIL | BUN | CRE | Brain | Kidneys | Heart | Whole liver | |
Vehicle | 40 ± 2 | 40 ± 2 | 117 ± 20 | 59 ± 13 | 176 ± 15 | 3.2 ± 0.8 | 5.9 ± 0.5 | 50.6 ± 5.7 | 0.30 ± 0.01 | 0.46 ± 0.02 | 0.26 ± 0.01 | 2.64 ± 0.09 |
Lorcaserin 1 mg/kg | 40 ± 2 | 37 ± 2 | 106 ± 10 | 30 ± 3 | 175 ± 13 | 3.4 ± 0.6 | 5.4 ± 0.5 | 42.0 ± 2.4 | 0.29 ± 0.01 | 0.49 ± 0.01 | 0.25 ± 0.01 | 2.79 ± 0.12 |
Lorcaserin 2 mg/kg | 33 ± 4 | 39 ± 3 | 90 ± 16 | 31 ± 7 | 160 ± 24 | 2.6 ± 0.6 | 5.1 ± 0.4 | 39.6 ± 8.7 | 0.30 ± 0.02 | 0.54 ± 0.03 | 0.27 ± 0.01 | 2.61 ± 0.09 |
These values all fall within normal range for SD rats (Petterino and Argentino-Storino 2006). ALB, albumin (g/L); GLOB, globulin (g/L); AST, aspartyl transaminase (U/L); ALT, alanine transaminase (U/L); ALP, alkaline phosphatase (U/L); TBIL, total bilirubin (μmol/L); BUN, blood urea nitrogen (mmol/L); CRE, creatinine (μmol/L).